Natural and Organic Cosmetic Products
Demand for natural and organic products is increasing, particularly in the cosmetic and personal care products markets. Brands and manufacturers are closely monitoring and creating products to answer this frenzy behaviour. The ISO - International Organization for Standardization has already set guidelines for technical definition and criteria applicable to natural and organic cosmetics. But do you know how to properly substantiate these claims? Here is a quick overview of the requirements to follow.

ISO 16128 – GUIDELINES FOR ‘NATURAL’ AND ‘ORGANIC’

ISO stands for the International Organization for Standardization, which is a worldwide federation of national standards bodies (ISO member bodies). It is an independent, non-governmental international organization that develops and publishes international standards for many industries (including the cosmetic industry).

ISO 16128 provides guidelines on definitions and criteria for natural and organic cosmetic ingredients and products, specific to the cosmetics sector. The main purpose of this ISO is to “encourage a wider choice of natural and organic ingredients in the formulation of a diverse variety of cosmetic products to encourage innovation”. It allows to calculate natural, natural origin, organic and organic origin indexes, according to ingredient categories set out in ISO 16128-1. Based on ingredient characterization, this ISO also presents a framework to determine the natural, natural origin, organic and organic origin content of products.

The first part of ISO 16128 (ISO 16128-1), published in 2016, defines cosmetic ingredient categories (natural ingredients, derived natural ingredients, organic ingredients and derived organic ingredients). While the second part (ISO 16128-2), published in 2017, permits the calculation of the 4 previously stated indexes.

A natural cosmetic product, according to this ISO, means that it has a minimum of 90% ingredients of natural origin in its composition. As for organic certified products, at least 95% of the natural ingredients must come from organic farming. Moreover, organic leave-on products must contain minimum 20% of the total ingredients from organic farming and organic rinse-off cosmetics need to have more than 10% of organic ingredients in their composition (non-emulsified products with more than 80% being minerals or mineral origin).

Any producer or manufacturer that wants to manufacture a natural or organic cosmetic product must follow ISO 16128.

Nevertheless, some organizations and companies suggest that ISO 16128 may not be adequate for a transparent standardization of these kind of cosmetic products. For example, ISO is not available free of charge, but for a purchase fee. If, as a consumer (that has no access to this ISO), I do not know how the natural index is calculated, how can I know what a natural ingredient means?

Besides ISO 16128, the COSMOS and Natrue certifications have been used for cosmetic products and raw materials, and products compliant with these two are clearly labelled as such. The ISO standard may be used simultaneously with the other certifications and provides a worldwide unified criteria, but it does not work as a marketing claim (or label).

Critical Catalyst is at your service to help your company achieve natural or organic certification and stay competitive.

References:

  1. ISO 16128-1:2016. Cosmetics — Guidelines on technical definitions and criteria for natural and organic cosmetic ingredients – Part 1: Definitions for ingredients.
  2. ISO 16128-2:2017. Cosmetics — Guidelines on technical definitions and criteria for natural and organic cosmetic ingredients – Part 2: Criteria for ingredients and products.

further
reading

medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »
medical devices

Amendments to the Transitional Provisions of the European Union MDR and IVDR

The proposed amendments aim to maintain patients’ access to a wide range of medical devices while ensuring the transition to the new framework. The ammendments proposal aims to extend the current transition period (Article 120 of the MDR), and it also deletes the ‘sell-off’ deadlines of both MDR and IVDR. The extension is staggered depending on the risk class of the device – until December 2027 for high-risk devices and December 2028 for medium and lower-risk devices.

Read More »
medical devices

EU MDR – Proposal for Extension of Transition Period

The transition to MDR has been slower than anticipated by the European Commission. Insufficient capacity of notified bodies and the low level of preparedness of manufacturers led to a proposal for extension of current MDR transition period with deadlines depending on the risk class of the devices.

Read More »
medical devices

MDCG 2022-18 – EU MDR Article 97

EU MDR Article 97 may be a temporary solution to avoid disruption of supply of Medical Devices on the EU Market. The MDCG 2022-18 presents a uniform approach for application of MDR Article 97 on non-compliant legacy devices under the conditions set by the competent authorities, while limiting the impact on the supply of safe and effective devices.

Read More »
parfum_fragrance_allergen_1
cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »